
Currently out of the existing stock ratings of Salim Syed, 209 are a BUY (82.94%), 43 are a HOLD (17.06%).
Analyst Salim Syed, currently employed at MIZUHO, has had 59.75% of price targets met with an average potential upside of 47.61%, reached in 306 days on average.
Salim Syed has documented 490 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASMB, Assembly Biosciences at 01-Sep-2026.
Analyst best performing recommendations are on UBX (UNITY BIOTECHNOLOGY).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) on 7/10/2023. The price target of $29 was fulfilled within 7 days with a profit of $11.64 (67.05%), with a performance score of 95.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Jan-2025
$542
$103.18 (23.51%)
$457
1 days ago
(18-Nov-2026)
Hold Since 21-Feb-2026
$430
$-8.82 (-2.01%)
$400
4 days ago
(15-Nov-2026)
Buy Since 05-Feb-2023
$515
$76.18 (17.36%)
$460
8 days ago
(11-Nov-2026)
4/5 (80%)
$47.94 (10.26%)
163
Hold Since 19-May-2025
$435
$-3.82 (-0.87%)
$388
15 days ago
(04-Nov-2026)
6/8 (75%)
$-25.28 (-5.49%)
41
Buy Since 27-Apr-2023
$536
$97.18 (22.15%)
$370
16 days ago
(03-Nov-2026)
3/4 (75%)
$57.52 (12.02%)
467
Which stock is Salim Syed most bullish on?
Which stock is Salim Syed most reserved on?
What Year was the first public recommendation made by Salim Syed?